MidEuropa, an independent private equity company, agreed to acquire a majority stake in Optegra, an European ophthalmology platform, from H2 Equity Partners, a Western European hands-on investment firm. Financial terms were not disclosed. “Optegra has a proven track record of delivering outstanding clinical outcomes and patient service, enabled by highly standardized pathways. We have built a strong foundation with H2 Equity Partners and we look forward to welcoming MidEuropa to accelerate our expansion and continue our strong engagement with our doctors, clinical teams and staff,” Peter Byloos, Optegra CEO.